Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers

In the 115 years since the discovery of Alzheimer’s disease (AD), our knowledge, diagnosis, and therapeutics have significantly improved. Biomarkers are the primary tools for clinical research, diagnostics, and therapeutic monitoring in clinical trials. They provide much insightful information, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mankhong, Sakulrat, Kim, Sujin, Lee, Seongju, Kwak, Hyo-Bum, Park, Dong-Ho, Joa, Kyung-Lim, Kang, Ju-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025524/
https://www.ncbi.nlm.nih.gov/pubmed/35453600
http://dx.doi.org/10.3390/biomedicines10040850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025524/
https://www.ncbi.nlm.nih.gov/pubmed/35453600
http://dx.doi.org/10.3390/biomedicines10040850

Ejemplares similares